Left ventricular noncompaction in patients with β-thalassemia: uncovering a previously unrecognized abnormality

Area of Science:

• Cardiology
• Hematology
• Medical Imaging

Background:

• Left ventricular noncompaction (LVNC) is a rare cardiomyopathy characterized by excessive myocardial trabeculations and deep recesses.
• While often congenital, acquired forms of LVNC are recognized, with recent reports suggesting a link to cardiac siderosis in beta-thalassemia.

Purpose of the Study:

• To evaluate the prevalence and potential risk factors of left ventricular noncompaction (LVNC) in transfusion-dependent patients with beta-thalassemia.
• To investigate the association between cardiac iron overload and LVNC in this patient population.

Main Methods:

• A cross-sectional study involving 135 transfusion-dependent beta-thalassemia patients undergoing cardiac iron assessment via magnetic resonance imaging (MRI).
• Predefined strict criteria were used to diagnose LVNC based on cardiac MRI findings.
• Statistical analysis was performed to identify risk factors and associations, excluding patients with neuromuscular or congenital heart disease.

Main Results:

• Left ventricular noncompaction (LVNC) was diagnosed in 18 patients (13.3%; 95% CI = 8.6-20.1) based on cardiac MRI.
• No significant differences in demographics, iron overload indices, or treatment factors were found between patients with and without LVNC.
• Patients with LVNC showed a trend towards higher heart failure rates (adjusted odds ratio = 1.77), though with considerable uncertainty.

Conclusions:

• The prevalence of left ventricular noncompaction (LVNC) is higher in patients with beta-thalassemia compared to the general population.
• Conventional risk factors did not explain the observed LVNC prevalence, indicating a need for further research into underlying mechanisms.
• Understanding LVNC in beta-thalassemia is critical due to the associated adverse cardiac outcomes and the significant mortality risk from cardiac disease in this population.